trending Market Intelligence /marketintelligence/en/news-insights/trending/_iL0mahgHUFEcaddN2MmDA2 content esgSubNav
In This List

Kalytera Therapeutics appoints CEO; COO resigns

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Kalytera Therapeutics appoints CEO; COO resigns

Kalytera Therapeutics Inc. appointed Robert Farrell permanent CEO.

Farrell had been serving as the company's interim CEO. He previously served Titan Pharmaceuticals Inc. as president and CEO and as CFO.

Additionally, Kalytera said David Bassa resigned as COO, while Pini Ben-Elazar resigned as a director.